Armata Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 634,047 | $1.50 M | 0.00% | 1.75% |
| VANGUARD GROUP INC | 11/13/2024 | 225,287 | $533,931 | 9.49% | 0.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 107,066 | $253,812 | 0.54% | 0.30% |
| EDGEWOOD MANAGEMENT LLC | 11/12/2024 | 100,000 | $237,000 | 0.00% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 75,382 | $178,655 | -16.60% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 46,496 | $110,196 | -3.53% | 0.13% |
| STATE STREET CORP | 11/14/2024 | 40,300 | $95,511 | 0.00% | 0.11% |
| SEACREST WEALTH MANAGEMENT, LLC | 10/16/2024 | 34,954 | $82,841 | 0.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 29,786 | $70,593 | -53.47% | 0.08% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 23,803 | $56,413 | 100.00% | 0.07% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 20,314 | $48,144 | 100.00% | 0.06% |
| CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 13,140 | $31,142 | 0.00% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 10,300 | $24,411 | -79.28% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 7,800 | $18,486 | -52.67% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 7,000 | $16,590 | 0.00% | 0.02% |
| UBS GROUP AG | 11/14/2024 | 2,357 | $5,586 | 235,600.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,005 | $4,752 | -60.41% | 0.01% |
| TRIFECTA CAPITAL ADVISORS, LLC | 10/16/2024 | 714 | $1,693 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 571 | $1,353 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 400 | $948 | 300.00% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 109 | $258 | 5,350.00% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 10/15/2024 | 100 | $237 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 26 | $62 | -3.70% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 1 | $1 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Armata Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Armata Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BANK OF AMERICA CORP /DE/: 634,047
VANGUARD GROUP INC: 225,287
GEODE CAPITAL MANAGEMENT, LLC: 107,066
EDGEWOOD MANAGEMENT LLC: 100,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 75,382
RENAISSANCE TECHNOLOGIES LLC: 46,496
3.82% of Armata Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.39 M shares in the last 24 months. This purchase volume represents approximately $2.72 M in transactions.